On Demand Recordings

8th Annual Spring to Life

CONFERENCE ON LEUKEMIAS 2021

May 14-15, 2021

Proudly Hosted by New York Oncology Hematology, PC

PROUDLY HOSTED BY:

EVENT INFORMATION

This is a recorded CME-Accredited On-Demand Online Activity
Upon registration, confirmation will be provided via email with login instructions

Next quote »

"Identification of molecular drivers has resulted in tailored treatments for our patients with non-small cell lung cancer which are not only more effective, but less toxic. It is essential the community oncologist have a keen knowledge of the most current precision testing techniques and incorporate newer therapies to provide state-of-the-art care to patients close to home."

-Makenzi Evangelist, M.D., New York Oncology Hematology

“The landscape of lung cancer with new biomarkers, immunotherapies, and targeted therapies is constantly evolving, and it is a challenge for the community oncologist to integrate and apply this new knowledge in daily clinical practice. Accessible continuing education forums are crucial to support this rapid evolution of cancer care."

-Nischala Ammannagari, M.D., New York Oncology Hematology

Registration

Please click here if you would like to be notified when registration is open. We hope to see you in 2020!

S2L | Registration HCP

First Name *

Last Name

Title Title

Specialty

Institution *

Street Address *

Additional Address

City *

State/Province *

ZIP/Postal *

Country *

Confirm Email

Phone

How did you hear about the conference? * How did you hear about the conference?

reCAPTCHA

Conference Platform

The 2021 Spring to Life conference was held live online utilizing a multimedia webcast and virtual conference platform to livestream the keynote, plenary sessions and ancillary events along with moderated Q&A panel discussions. The conference was recorded and will be offered on-demand for 30 days following the live conference.

PROGRAM OVERVIEW

New York Oncology Hematology (NYOH) has identified an ongoing unmet need for medical education in the area of hematologic malignancies. To meet this need, NYOH, in collaboration with The University of Chicago Pritzker School of Medicine, myMedEd, Inc., the American Cancer Society, the Leukemia & Lymphoma Society and a panel of expert faculty from the academic, research, and community practice settings, developed an accredited, multi-supported, 2-day educational conference. With an expanded agenda the conference is offering 8.5-hrs of continuing medical education. This is the eighth of these annual conferences that include programming for cancer clinicians.

EDUCATIONAL GOAL

The purpose of this conference is to educate practitioners and update their knowledge of the biologic pathways associated with Leukemias and the existing and emerging therapies for the management of patients with leukemia.

TARGET AUDIENCE

The target audience for this conference is the medical oncologist, hematologists, pathologists, oncology nurses, advanced practice providers, family and primary care practitioner, allied health professional, and any other individuals with an interest in the care of patients with Leukemias.

LEARNING OBJECTIVES

After completing this activity, participants will be able to:

Describe the evolving gene mutational spectrum of malignant myeloid disease and the treatment paradigms of acute myeloid leukemia in the young fit and elderly or unfit populations
List the advances in biologic knowledge and treatments, including non-chemotherapy based treatments for acute lymphoblastic leukemia from young adults to the elderly
Review the current state of allogeneic hematopoietic stem cell transplantation in the curative treatment of acute leukemias
Discuss the shift in knowledge and treatment decision making in chronic lymphocytic leukemia and the management of chronic myeloid leukemia, including selecting for treatment free remission
Explain the current knowledge on hematologic complications of COVID-19 and the data and contributors to outcomes disparities in Americans with hematologic malignancies

DOWNLOAD AGENDA

PLANNING COMMITTEE

Ira Zackon, MD (Conference Chair)
New York Oncology Hematology, Immediate Past President
Hematologist/Medical Oncologist
NYOH Albany Medical Center
Clinical Assistant Professor
Albany Medical College
Albany, NY

Reju George, MD (Conference Co-Chair)
Hematologist
New York Oncology Hematology
Albany, NY

Faculty

Mary Cushman MD, MSc.
Professor of Medicine
University of Vermont and State Agricultural College
Burlington, VT

Matthew S. Davids, MD, MMSc
Associate Professor of Medicine, Harvard Medical School
Director of Clinical Research, Division of Lymphoma
Dana-Farber Cancer Institute
Boston, MA

Daniel J. DeAngelo, MD, PhD
Chief, Division of Leukemia
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, MA

Jacqueline S. Garcia, MD
Instructor in Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, MA

Aaron Goldberg, MD, PhD
Assistant Attending Physician
Memorial Sloan Kettering Cancer Center
New York, NY

Andrew Hantel, MD
Instructor in Medicine
Dana-Farber Cancer Institute and Harvard Medical School
Boston, MA

Muhammad Azam Hussain, MD
Hematologist
New York Oncology Hematology
Albany, NY

Alla Keyzner, MD
Assistant Professor
Associate Director of Allogeneic Stem Cell Program
Tisch Cancer Institute Bone Marrow & Stem Cell Transplantation
Icahn School of Medicine at Mount Sinai
New York, NY

Ross L. Levine, MD
Chief, Molecular Cancer Medicine Service, HOPP
Member, Human Oncology and Pathogenesis Program
Attending Physician, Leukemia Service, Department of Medicine
Center for Epigenetics Research
Center for Hematologic Malignancies
Laurence Joseph Dineen Chair in Leukemia Research
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
New York, NY

Esperanza B. Papadopoulos, MD
Attending Physician and Member
Associate Vice Chair of Medicine
Inpatient Operations, Division of Hematologic Malignancies
Clinical Director, Inpatient Adult BMT Unit
Department of Medicine
Koch Center for Cancer Care
Memorial Sloan Kettering Cancer Center
New York, NY

Mihir Raval, MD, MPH
Clinical Assistant Professor
Hematology and Stem Cell Transplant
Albany Medical Center
New York Oncology and Hematology
Albany, NY

Rizwan Romee, MD
Associate Professor of Medicine at Harvard Medical School
Director of the Haploidentical Stem Cell Transplantation Program at Dana-Farber Cancer Institute
Boston, MA

Wendy Stock, MD, MS
Professor of Medicine
University of Chicago Medicine
Chicago, IL

Michael D. Robek, PhD

Professor
Department of Immunology & Microbial Disease
Albany Medical College
Albany, NY

Stephen H. Wrzesinski MD, PhD

Director of Immunooncology and Cellular Therapies
New York Oncology Hematology
Clinical Assistant Professor of Medicine
Albany Medical Center
Albany, NY

Ira Zackon, MD (Chair)

Medical Hematology and Oncology Director
NYOH Hematology Stem Cell Transplant Program
Hematologist/Oncologist NYOH
Clinical Assistant Professor
Albany Medical College
Albany, NY

Host

The 8th Annual Spring to Life: Conference on Leukemias 2021 is proudly hosted by:

ACCREDITATION

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and New York Oncology Hematology, PC, and in collaboration with myMedEd, Inc. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 8.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME, please consult your professional licensing board.

Assurance of Balanced, Unbiased, and Fair Content:

It is the policy of The University of Chicago Pritzker School of Medicine to ensure balance, independence, objectivity, and scientific rigor in all its individually provided or jointly provided educational activities. Individuals who are in a position to control the content of any educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Mechanisms to ensure that presentations are free from commercial bias are in place. Faculty will also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.

The mission of Spring to Life™ is to reflect and transmit all that is evolving in the whole of the field of oncology. The annual conference continues to bring together faculty speakers that reflect local, regional and national expertise in the field. This collaboration of community-based oncologists with academic leaders highlights the impact of the research that advances our understanding and ultimately impacts the lives of our patients whom we serve.

Click on the links below to view the programs from years past.

2014 The Acute Leukemias - AML and ALL

2015 Aggresive B-Cell Non-Hodgkin Lymphomas

2016 Plasma Cell Diseases

2017 Myeloproliferative Neoplasms (MPNs)

2018 Incident Lymphoid Malignancies

2019 Harnessing the Power of our Immune System in Cancer Therapy

2020 Lung Cancer

Thank you to the collaborators, educational grant providers, sponsors and exhibitors, past and present, who have made this event possible: